All recalls
Every recall from CPSC, FDA, USDA and NHTSA, newest first. Each one links to the agency's official notice. Looking for one product? Check a product.
2,237 recalls ยท page 29 of 45
-
Class IIofficial
Aspen Biopharma Labs Pvt., Ltd. recalls Alprostadil Container Description: Amber color bottleCGMP Deviations
-
Class IIofficial
Aspen Biopharma Labs Pvt., Ltd. recalls Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black polCGMP Deviations
-
Class IIofficial
Aspen Biopharma Labs Pvt., Ltd. recalls Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in AluminuCGMP Deviations
-
Class IIofficial
Aspen Biopharma Labs Pvt., Ltd. recalls Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottleCGMP Deviations
-
Class IIofficial
Aspen Biopharma Labs Pvt., Ltd. recalls Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly baCGMP Deviations
-
Class IIofficial
Padagis US LLC recalls Estradiol GelDefective Container: Some packets may not be fully sealed, potentially allowing for loss of Ethanol from the product.
-
Class IIofficial
Sun Pharmaceutical Industries Inc recalls Morphine Sulfate Extended-Release TabletsFailed Dissolution Specifications
-
Class IIofficial
AvKARE recalls Silodosin CapsulesSubpotent Drug: Out of Specification (OOS) result for De hydro Impurity (0.654%) for 18 M Stability sample and low assay 94.9% (specification of NLT 95.0% NMT 105%)
-
Class IIofficial
Fagron Compounding Services recalls fentaNYL Citrate In Sodium Chloride 1600mcg/100mL (16 mcg per mL) CIILack of Assurance of Sterility
-
Class Iofficial
Alvogen, Inc recalls Fentanyl Transdermal System CIIDefective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
-
Class IIofficial
Direct Rx recalls CIPROFLOXACIN OPHTH SOLUTIONDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Potassium Chloride Extended-Release TabletsFailed Dissolution Specifications.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Atomoxetine CapsulesCGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
-
Class Iofficial
Ascent Consumer Products Inc. recalls SinuCleanse Soft Tip Squeeze Bottle Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2Microbial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
-
Class Iofficial
Ascent Consumer Products Inc. recalls SinuCleanse Premixed SALINE PACKETS (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mg) for NasalMicrobial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
-
Class Iofficial
Ascent Consumer Products Inc. recalls SinuCleanse Soft Tip NETI POT Nasal Wash System (sodium bicarbonate USP 700 mg and sodium chloride USP 2300 mgMicrobial Contamination of Non-Sterile Products: Bacterial contamination with Staphylococcus aureus
-
Class IIofficial
RemedyRepack Inc. recalls Carvedilol 25 mg TabletCGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit.
-
Class IIofficial
Sky Packaging recalls HydrALAZINE HydrochlorideFailed Impurities/Degradation Specifications
-
Class IIofficial
Sky Packaging recalls HydrALAZINE HydrochlorideFailed Impurities/Degradation Specifications
-
Class IIofficial
FDC Limited recalls Timolol Maleate Ophthalmic Solution USPDefective Container: Unable to get the solution out of the bottle as the spike of the cap was lodged in the nozzle of the product bottle.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
-
Class IIofficial
Glenmark Pharmaceuticals Inc., USA recalls Carvedilol TabletsCGMP Deviations:N-Nitroso Carvedilol I impurity (NNCI-I) were found to be failing per current FDA recommended limit.
-
Class IIofficial
AvKARE recalls Irbesartan Tablets USPOut of Specification for Dissolution
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Lorazepam TabletsFailed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Lorazepam TabletsFailed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Lorazepam TabletsFailed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
-
Class Iofficial
Provepharm Inc. recalls Phenylephrine HCl InjectionPresence of Particulate Matter.
-
Class IIIofficial
The W.S. Badger Company, Inc. recalls BADGER 50Labeling: Missing Label: The finished product potentially missing the labeling with the drug facts panel, bar code and directions for use.
-
Class IIofficial
McKesson recalls Inflectra (infliximab-dyyb)cGMP Deviations: Product intended for quarantine was inadvertently distributed.
-
Class IIIofficial
Appco Pharma LLC recalls Venlafaxine Extended-Release TabletsFailed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet
-
Class IIofficial
The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories recalls Duloxetine Delayed-Release Capsules USPCGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Duloxetine above the FDA recommended acceptable intake limit
-
Class IIofficial
Teva Pharmaceuticals USA, Inc recalls Granix (tbo-filgrastim) Injection 300 mcg/0.5 mLFailed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit
-
Class IIofficial
Johnson, S C and Son, Inc recalls babyganicsFailed stability specifications: during routine stability monitoring quality concerns were identified. Physical separation for ingredients was observed.
-
Class IIofficial
Amerisource Health Services LLC recalls Clobazam TabletsPresence of Foreign Tablets/Capsules
-
Class IIIofficial
PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Guaifenesin and Codeine Phosphate Oral Solution USPSuperpotent; sodium benzoate preservative
-
Class IIofficial
Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 30 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.
-
Class IIofficial
Rising Pharma Holding, Inc. recalls Duloxetine Delayed-Release Capsules USP 20 mgCGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.